SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-019333
Filing Date
2020-02-12
Accepted
2020-02-12 17:03:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm207710d1_424b5.htm 424B5 424013
2 GRAPHIC tm207710d1_424b5img001.jpg GRAPHIC 2915
3 GRAPHIC tm207710d1_424b5img002.jpg GRAPHIC 13048
4 GRAPHIC tm207710d1_424b5img003.jpg GRAPHIC 7371
  Complete submission text file 0001104659-20-019333.txt   457711
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221443 | Film No.: 20605231
SIC: 2836 Biological Products, (No Diagnostic Substances)